Daniel Addo-Gyan1, Haruka Matsushita1, Enya Sora1, Tsubasa Nishi2, Masao Yuda2, Naoaki Shinzawa1, Shiroh Iwanaga3,4. 1. Department of Environmental Parasitology, Graduate School of Medical and Dental Sciences, Tokyo Medical and Dental University, Bunkyo-ku, Tokyo, Japan. 2. Laboratory of Medical Zoology, Department of Medicine, Mie University, Kurimamachi Yacho, Tsu, Mie, Japan. 3. Department of Molecular Protozoology, Research Institute for Microbial Diseases, Osaka University, Yamadaoka, Suita, Osaka, Japan. 4. Center for Infectious Disease Education and Research (CIDER), Osaka University, Yamadaoka, Suita, Osaka, Japan.
Abstract
Spatial arrangement of chromosomes is responsible for gene expression in Plasmodium parasites. However, methods for rearranging chromosomes have not been established, which makes it difficult to investigate its role in detail. Here, we report a method for splitting chromosome in rodent malaria parasite by CRISPR/Cas9 system using fragments in which a telomere and a centromere were incorporated. The resultant split chromosomes segregated accurately into daughter parasites by the centromere. In addition, elongation of de novo telomeres were observed, indicating its proper function. Furthermore, chromosome splitting had no effect on development of parasites. Splitting of the chromosome is expected to alter its spatial arrangement, and our method will thus be useful for investigating its biological role related with gene expression.
Spatial arrangement of chromosomes is responsible for gene expression in Plasmodium parasites. However, methods for rearranging chromosomes have not been established, which makes it difficult to investigate its role in detail. Here, we report a method for splitting chromosome in rodent malaria parasite by CRISPR/Cas9 system using fragments in which a telomere and a centromere were incorporated. The resultant split chromosomes segregated accurately into daughter parasites by the centromere. In addition, elongation of de novo telomeres were observed, indicating its proper function. Furthermore, chromosome splitting had no effect on development of parasites. Splitting of the chromosome is expected to alter its spatial arrangement, and our method will thus be useful for investigating its biological role related with gene expression.
Plasmodium parasites, which are causative agents of malaria, possess a complex life cycle consisting of distinctive developmental stages between mosquitos and animals. Each developmental stage is controlled by the stage-specific gene regulation, for which sequence-specific transcription factors [1] and epigenetic regulators are responsible [2, 3]. In addition to these, the spatial arrangement of chromosomes in the nucleus is recently considered to participate in the regulation of gene expression in parasites. For instance, chromosome conformation capture analysis using next-generation sequencing (Hi-C) has shown that heterochromatic regions scattered throughout chromosomes form a cluster at the periphery of the nucleus, which are known as a repressive center [4, 5]. Dissociation from the repressive center will change the chromatin state from heterochromatin to euchromatin, which triggers activation of transcription [6, 7]. Since multi-gene families of infected red blood cell (RBC)-surface antigens and the sex-specific transcription factor are located in these heterochromatic regions [8], their dissociation may be responsible for antigenic variation and sexual development. Furthermore, the three-dimensional size and volume of chromosomes change during the progression of asexual development in RBC, which may be responsible for the changes in transcriptional activity [4]. To investigate the biological role of the spatial arrangement of chromosomes in gene expression, engineering large genomic regions is required. However, there are no established methods in Plasmodium parasites at present.The CRISPR/Cas9 system is a useful technique for engineering the genes of Plasmodium parasites [9]. In this system, a gene is modified through two steps as follows: the targeted genomic locus cleavage by the Cas9-single guide RNA (sgRNA) complex, and the induced double-strand break repair by homology-directed recombination (HDR) using donor template DNA. In our previous study, we generated the Cas9-expressing rodent malaria parasite (P. berghei), that successfully engineered the genes with high efficiency, by transfecting these parasites with linear donor template DNA, and the plasmid encoding sgRNA [10]. With this system, we were able to remove more than 50 kbp of the subtelomere region of chromosome 1 [10]. Briefly, we cleaved the border of the subtelomere and non-telomeric chromosomal region on chromosome 1, followed by HDR providing the telomeric sequence at the cleaved end of the chromosome. The newly generated telomere functioned properly, which ensured the replication of the de novo chromosome end. The resultant transgenic parasites that carries the truncated chromosome 1 had no growth defects during both asexual and sexual development in RBC. This truncation of the chromosome suggests that the large-scale editing of chromosomes could be achieved by the CRISPR/Cas9 system.In this study, we developed a method for splitting the chromosome using the CRISPR/Cas9 system. In addition to a telomere, we used a centromere which is responsible for chromosome segregation into daughter cells during nuclear division. After confirming the split of the chromosome, its effect on the development of the parasites was examined. Furthermore, to test the versatility of this method, we attempted to cleave the chromosome at different loci. Our method enables us to split chromosomes in a flexible manner, which allows for a variety of future applications including large-scale genome editing.
Materials and methods
Animal experiments
All animal experiments were carried-out in accordance with the guidelines for the care and use of laboratory animals, approved by the animal experimentation committee of the Tokyo Medical and Dental University. For all experiments requiring the use of total mouse blood, mice were deeply anesthetized using isoflurane, followed by collection of total blood by cardiac puncture, and euthanized by cervical dislocation immediately after collection. At the end of all mice experiments, euthenization was performed using 70% carbon dioxide and 30% oxygen mixture in a gas chamber, ensuring that mice were completely dead before removal from the chamber.
Construction of plasmid having the guide RNAs
A 19-bp sequence of guide RNA (gRNA) was designed upstream of the protospacer-adjacent motif (PAM), and a pair of complementary oligonucleotides was synthesized for each target site. The gRNA was transcribed by PfU6 (U6 spliceosomal RNA, PF3D7_1341100) promoter. Since the PfU6 promoter requires a guanosine nucleotide to initiate transcription, a guanosine was added at the 5’ end of the designed oligonucleotide that encoded the sense sequence. In addition, the oligonucleotides were designed to generate overhangs to be used for cloning into BsmBI-digested psgRNA1 plasmid [10]. The cloned gRNA was placed under PfU6 promoter and fused with a tracrRNA, which generated an sgRNA. The psgRNA1 plasmid has human dihydroreductase gene as drug selectable marker. Thus, the transfected parasite with this plasmid can be selected using pyrimethamine. The designed oligonucleotides were shown in S1 Table.
Preparation of linear donor templates with telomere and centromere
The DNA fragment used for HDR was amplified by PCR using primer set (S1 Table) and then cloned upstream of telomere sequence of pArm_L plasmid (S1 Fig). The cloned DNA fragment was excised together with the telomere sequence by restriction digestion of 10 μg of resultant plasmid with SalI and PmeI. This linear DNA fragment was used for HDR with the centric chromosome (Chromosome 1 fragment with the original centromere after cleavage) after cleavage by the Cas9-sgRNA complex. Another DNA fragment, which was used for HDR with the acentric chromosome (Chromosome 1 fragment lacking a centromere after cleavage), was amplified and cloned upstream of both telomere and centromere of pArm_R plasmid (S1 Fig). The linear DNA fragment with the centromere and telomere was excised form the resultant plasmid by digestion with SalI and PmeI, and used for the transfection experiment.
Transfection of parasites
Transfection of parasites had been described previously [11]. Briefly, two linear forms of DNA fragments that had a telomere only, and both telomere and centromere were co-introduced with the psgRNA1 plasmid having the sgRNA, into purified schizonts (1 x 107 parasites) of P. berghei ANKA using the parasite nucleofector II kit and the Nucleofector II device with the U-033 program (Lonza). Transfected parasites were injected intravenously into 5–7 weeks old female ddY mice, immediately after electroporation. Treatment with pyrimethamine was initiated 30 hours post- infection and continued for 5 days, followed by withdrawal of the drug. Transfection experiments for generating transgenic parasites were carried out independently in duplicate. The clonal transgenic parasite lines were obtained by limiting dilution procedure.
Contour-Clamped Homogenous Electric Field (CHEF) electrophoresis analysis
Whole blood from mice inoculated with transgenic parasites were used to make DNA agarose plugs (at approximately 1.0 x 108 parasites / plug) as described in a previous study [12]. Chromosomes were separated on a 1% pulse-field certified agarose gel on the CHEF Mapper XA system (Bio-Rad) under the following conditions: 0.5 x TBE buffer, temperature: 14°C, switch time: 10–80 sec, runtime: 20 hours, included angle: 120°, voltage gradient: 6 V/cm.
Southern hybridization analysis
Whole blood from mice inoculated with transgenic parasites was filtered through the cellulose powder D columns (Advantec, #49020040) to remove leucocytes. The RBCs were collected by centrifugation and lysed with a lysis buffer (1.5 M NH4Cl, 0.1 M KHCO3, and 0.01 M EDTA) to obtain the parasites. The genomic DNA was purified from the obtained parasites as described previously [12]. The genomic DNA purified from split-Ch1-1053 and split-Ch1-1116 parasites were digested with EcoRI, followed by blotting onto a nylon membrane. The probe DNA was labelled with DIG according to the manufacturer’s instructions (Roche Diagnostics GmbH) and used for hybridization with genomic DNA blotted on the membrane. Signals derived from hybridized DNA was detected using the Chemidoc MP system (Bio-rad).Chromosomes separated by CHEF electrophoresis were transferred onto a nylon membrane and hybridized with probes specific for PBANKA0112500 and PBANKA_0104900. Subsequent Southern hybridizations were performed in a similar manner as described above.
Evaluation of asexual multiplication and merozoite formation
Asexual multiplication in RBCs was evaluated by monitoring parasitemia in infected mice. The 1,000 iRBCs were injected intravenously into naive mice and the progress of the parasitemia was examined every 12 hours using a Giemsa-stained thin blood smear. All experiments were performed in triplicates. Averages of parasitemia between split-Ch1-1116 and parental pbcas9 parasites were compared using a t-test. The growth rate was calculated based on the approximate growth curve. The curve was represented by the following equation;
Where P is the parasitemia; A is the constant value; D is the day post-infection; and ex is the growth rate.The mice were inoculated with split-Ch1-1116 intra-peritoneally. At a parasitemia of 2–3%, whole blood taken by cardiac puncture was washed once with 20 ml RPMI medium containing 20% fetal calf serum (FCS). The infected RBCs were cultured with 25 ml of culture medium (RPMI 1640, 20% FCS, 500 μL penicillin-streptomycin) under low oxygen conditions: 5% oxygen, 5% carbon dioxide, 90% nitrogen at 37°C for 16 hours. Giemsa-stained thin smears were prepared and the number of merozoites per mature schizont was counted for 100 schizonts.
Evaluation of exflagellation and ookinete formation
Exflagellation of male gametes was assessed by counting the number of exflagellation centres. Mice were pre-treated with an intraperitoneal injection of 0.2 ml phenylhydrazine (6 mg/ml in PBS) 3 days prior to parasite infection to stimulate reticulocyte formation. 1 x 105 iRBCs were intravenously inoculated into the phenylhydrazine-treated mice. At 5 days post-infection, infected blood was collected from the tail vein and diluted twenty-fold with ookinete culture medium (RPMI1640 containing 100 μM xanthurenic acid, 50 mg/l hypoxanthine, 25 mM HEPES, 24 mM NaHCO3, 50 U/ml penicillin, 50 μg/ml streptomycin, and 20% FCS, adjusted to pH 7.5). The number of exflagellation centres per 10,000 RBC was counted using Burker-Turk counting chambers after incubation at 20°C for 10 min.Ookinete formation was evaluated as previously described [13]. Briefly, mice were pre-treated with phenylhydrazine and infected as in the exflagellation assay described above. At 5 days post-infection, infected blood was collected from mice, and leukocytes were removed using cellulose powder D columns. Leukapheresis blood was diluted 10-fold with ookinete culture medium. Diluted blood samples were incubated at 20°C for 22–24 h. Giemsa-stained thin smears were prepared and assessed for ookinetes. The number of mature and immature ookinetes were counted, and the mature ookinete rate was calculated as follows:
Results
Splitting chromosome 1 of Plasmodium berghei
In this study, we selected chromosome 1 as a target for proving the experimental concept of chromosome splitting. The chromosome 1 of P. berghei consists of 515,659bp and 136 genes. The centromere of this chromosome is located at 389,413–390,757, and the sub-telomeres are located within less than 50 kbp from both ends (https://plasmodb.org/). To split the chromosome, we utilized the CRISPR/Cas9 system using the donor template DNAs in which telomere and a centromere sequences were incorporated. The telomeres of P. berghei are composed of a repetition of a degenerated motif (5’-GGGTTYA, where Y is T or C) [14], and the centromeres of this parasite are highly A/T rich sequences and are the smallest regional centromeres, of which sizes range from 1.5 to 3.0 kb. In this study, the centromere from chromosome 5 was used. Splitting of the chromosome was carried out by two steps as follows: specific cleavage of the chromosome by the Cas9-sgRNA complex and integration of the telomere and centromere at the cleaved ends of chromosome by HDR (Fig 1). When the chromosome was cleaved, centric and acentric chromosome fragments were produced. The ends of both those centric and acentric chromosomes would be protected by the introduced telomere. The centric chromosome would segregate accurately into daughter cells, but the acentric chromosome would not, due to the lack of centromere (Fig 1). Thus, to make acentric chromosome segregate, the addition of centromere would be necessary.
Fig 1
Experimental scheme of chromosome splitting.
(A) pbcas9 is the transgenic parasite expressing the Cas9 nuclease in the nucleus. (B) Chromosome 1 is cleaved by the Cas9, which generates a centric fragment and an acentric fragment. The white circle is the original centromere. (C) The cleaved end of the centric chromosome fragment is repaired by homologous recombination using the donor DNA with a telomere sequence (blue triangle). While, that of the acentric chromosome fragment is repaired using the donor template with both a centromere (red circle) and telomere (blue triangle). The split chromosomes will be maintained in the parasite due to the centromere and telomere. (D and E) In contrast, if the cleaved end of the acentric chromosome fragment is repaired using the donor template with only a telomere, the parasite will lose the split chromosome due to the failure of its segregation. As a result, the parasite will die due to this loss of a chromosome.
Experimental scheme of chromosome splitting.
(A) pbcas9 is the transgenic parasite expressing the Cas9 nuclease in the nucleus. (B) Chromosome 1 is cleaved by the Cas9, which generates a centric fragment and an acentric fragment. The white circle is the original centromere. (C) The cleaved end of the centric chromosome fragment is repaired by homologous recombination using the donor DNA with a telomere sequence (blue triangle). While, that of the acentric chromosome fragment is repaired using the donor template with both a centromere (red circle) and telomere (blue triangle). The split chromosomes will be maintained in the parasite due to the centromere and telomere. (D and E) In contrast, if the cleaved end of the acentric chromosome fragment is repaired using the donor template with only a telomere, the parasite will lose the split chromosome due to the failure of its segregation. As a result, the parasite will die due to this loss of a chromosome.We selected PBANKA_0111600, which encodes a rhoptry protein (ROP14) as a target for the cleavage site (Fig 2A). The ROP14 which is located at 444,999–448,675 of chromosome 1, and since it is not essential for asexual development in RBC, it can be disrupted without deleterious effects in this developmental stage [15]. The sgRNA plasmid specific for rop14 and the two linear donor templates were co-introduced into the pbcas9 parasite, in which cas9 of Streptococcus pyogenes was integrated at the cssu locus (Fig 2A) [10]. Parasites emerged in peripheral blood 2 days after removal of drug selective pressure, and subsequent genotyping analysis by PCR indicated the presence of the transgenic parasites with split chromosomes, while there was also the wild-type parasites present. The parasite line with split chromosomes were further cloned by limiting dilution and named as split-Ch1-1116. The genotyping analysis of split-Ch1-1116 parasite indicated the splitting of chr1 (Fig 2B).
Fig 2
CRISPR/Cas9-based chromosome split.
(A) The PBANKA_011600 was cleaved by the Cas9-sgRNA complex, followed by HDR with the donor template DNA including only telomere, and telomere and centromere. (B) The genotyping PCR was performed using the sets of primers indicated at the bottom. (C) Southern hybridization analyses of the transgenic parasites, which are split-Ch1-1116 and -1053, detected the split chromosomes. The probe DNA used in each analysis is shown at the bottom. The information about the probe are described in S2 and S3 Figs. (D) Southern hybridization shows the telomere extension in the transgenic parasite.
CRISPR/Cas9-based chromosome split.
(A) The PBANKA_011600 was cleaved by the Cas9-sgRNA complex, followed by HDR with the donor template DNA including only telomere, and telomere and centromere. (B) The genotyping PCR was performed using the sets of primers indicated at the bottom. (C) Southern hybridization analyses of the transgenic parasites, which are split-Ch1-1116 and -1053, detected the split chromosomes. The probe DNA used in each analysis is shown at the bottom. The information about the probe are described in S2 and S3 Figs. (D) Southern hybridization shows the telomere extension in the transgenic parasite.To confirm the split of chromosome 1, we performed CHEF-electrophoresis of split-Ch1-1116, followed by Southern hybridization using probes specific to each split chromosome fragment: two DNA probes were derived from PBANKA_0104900 and PBANKA_0112500, which are located on the left and the right chromosome fragments, respectively (Figs 2C and S2A). The signals of both left and right chromosome fragments were detected at the expected sizes of approximately 450 kbp and 60 kbp, respectively (Fig 2C). Similar results were obtained from another biologically independent split-Ch1-1116 parasite. These results demonstrate that chromosome could be divided by CRISPR/Cas9 system using telomere and centromere sequences.In the previous study, when a telomere sequence was added to the end of cleaved chromosome, de novo elongation of the telomere occurred [10]. To investigate whether a similar elongation would be observed in this study, we performed Southern hybridization analysis of the telomere end of the split chromosome. The signal derived from the right chromosome fragment was detected at approximately 1.3 kbp, when the digested genomic DNA of split-Ch1-1116 was hybridized with the probe DNA from the proximal region of the additional telomere (Figs 2D and S2B). On the other hand, in the negative control using the linear donor template, a signal was detected at 0.8 kbp (Figs 2D and S2B). This size difference between those two signals indicated the de novo elongation of the telomere at the end of split chromosome. In addition, the signal is broad, and its width is maintained within about 0.4 kbp, suggesting that de novo telomere extension is regulated within a certain length. These results suggested that the introduced telomere sequence was recognized by telomerase in split-Ch1-1116 like the original telomere, allowing for the stable maintenance of the split chromosome in the parasites.To examine the versatility of this method, we split chromosome 1 at another genomic locus, where PBANKA_0105300 was located (S3A Fig). The PBANKA_0105300 is located at 216,483–221,962 of chromosome 1, encodes the unknown-function Plasmodium protein and is not essential for asexual development in RBCs [15]. Transfection experiments using the plasmid having the sgRNA and two linear donor templates were performed, and the clonal transgenic parasite obtained by the limiting dilution was named split-Ch1-1053 (S3B Fig). The genotyping and Southern hybridization analyses of split-Ch1-1053 demonstrated the splitting of chromosome 1: PCR products specific for the split left and right chromosome fragments were amplified (S3C Fig). In addition, the signals derived from those two fragments were detected at expected sizes, which were approximately 365 kbp and 225 kbp (Fig 2C). Furthermore, the elongation of the de novo telomere was confirmed by Southern analysis (S3D and S3E Fig). These results showed that any genomic locus of interest could be split using this method.
Effect of splitting the chromosome on the development of parasites
Plasmodium parasites undergo atypical mitotic division during asexual multiplication in RBCs, whereby a multinucleate syncytium, schizont, is formed. All 14 chromosomes segregate accurately into those divided nuclei in schizonts, followed by the formation of RBC-invasive merozoite. As a result of splitting the chromosome, the total number of chromosomes became 15, which might have some influence on mitotic division. To examine this, we compared the asexual multiplication of split-Ch1-1116 parasite to that of pbcas9. The result clearly showed comparable growth of both parasite lines in RBCs. The growth rates of split-Ch1-1116 and pbcas9 were estimated as 5.6 and 6.4, respectively, indicating that there was no significant defect of asexual multiplication in split-Ch1-1116 (Fig 3A). Moreover, split-Ch1-1116 formed a comparable number of nuclei in schizonts alongside pbcas9, and no defects in their ring forms and trophozoites other than schizonts were observed (Fig 3B and 3C). Taken together, these results showed that an increase in chromosome number due to splitting did not affect mitotic division of the parasites, and that the parasite was able to multiply asexually in RBCs without any defects, despite its chromosome being split.
Fig 3
Asexual development of the split-Ch1-1116 parasites.
(A) The growth of the split-Ch1-1116 parasites, which is indicated by the blue line, was comparable to that of the parental pbcas9 parasites, which is shown by the black line. The points and error bars represent the mean and standard error of the mean of triplicate values. Distributions for each day were compared using the unpaired t-test (not significant). (B) The morphologies of the parasites during asexual development were similar between pbcas9 (upper) and split-Ch1-1116 (lower). The bar indicates 5 μm. (C) The number of merozoites per schizonts of the split-Ch1-1116 parasite was comparable to that of the parental pbcas9 strain. The middle line, top, and bottom of the box, top and bottom whiskers are the median, 75th and 25th percentiles, and the maximum and minimum values respectively. Distributions were compared using the unpaired t-test (not significant).
Asexual development of the split-Ch1-1116 parasites.
(A) The growth of the split-Ch1-1116 parasites, which is indicated by the blue line, was comparable to that of the parental pbcas9 parasites, which is shown by the black line. The points and error bars represent the mean and standard error of the mean of triplicate values. Distributions for each day were compared using the unpaired t-test (not significant). (B) The morphologies of the parasites during asexual development were similar between pbcas9 (upper) and split-Ch1-1116 (lower). The bar indicates 5 μm. (C) The number of merozoites per schizonts of the split-Ch1-1116 parasite was comparable to that of the parental pbcas9 strain. The middle line, top, and bottom of the box, top and bottom whiskers are the median, 75th and 25th percentiles, and the maximum and minimum values respectively. Distributions were compared using the unpaired t-test (not significant).We next examined whether splitting the chromosome affects sexual development and fertilization. It is known that some part of the parasites undergoes sexual commitment during asexual development in RBCs, then develop into female and male gametocytes. These gametocytes fertilize in the midgut of Anopheles mosquitos after blood feeding and develop into zygotes, followed by the formation of ookinetes which is a midgut invasive form. Meiosis occurs in zygotes, and the parasites then return to haploid from diploid [16]. Here, we observed both female and male gametocytes of split-Ch1-1116 in peripheral blood. In addition, exflagellation of male gametes was induced by xanthurenic acid, and the number of ex-flagellation centres of split-Ch1-1116 were comparable to that of pbcas9 (Fig 4A). A comparison of the morphologies of the ookinetes in giemsa-stain smears for both split-Ch1-1116 and pbcas9 parasites showed no significant difference (Fig 4B), suggesting not only normal ookinete formation, but also zygote development. Furthermore, the average of mature ookinete rates was comparable in split-Ch1-1116 (86.4%) to the pbcas9 parasites (85.0%) (Fig 4C). These results suggested that splitting the chromosome did not interfere with asexual multiplication, sexual development, fertilization, and ookinete formation including meiosis.
Fig 4
Sexual development of the split-Ch1-1116 parasites.
(A) The number of exflagellation centers of split-Ch1-1116 parasites were comparable to that of pbcas9 parasites. The column and error bars indicate the mean and standard error from biological triplicates. (B and C) Ookinete shape and conversion rate were normal in the split-Ch1-1116 parasites. The columns and error bars indicate the mean and standard error of the mean from biological triplicates. Distributions in A and C were compared using the unpaired t-test (not significant). The bar indicates 5 μm.
Sexual development of the split-Ch1-1116 parasites.
(A) The number of exflagellation centers of split-Ch1-1116 parasites were comparable to that of pbcas9 parasites. The column and error bars indicate the mean and standard error from biological triplicates. (B and C) Ookinete shape and conversion rate were normal in the split-Ch1-1116 parasites. The columns and error bars indicate the mean and standard error of the mean from biological triplicates. Distributions in A and C were compared using the unpaired t-test (not significant). The bar indicates 5 μm.
Discussion
Elucidating the mechanism of the regulation of gene expression is essential for understanding parasite’s complex life cycle. Recent advanced analysis, such as Hi-C analysis suggests that, in addition to sequence-specific transcriptional factors and epigenetic regulators, the spatial arrangement of chromosomes is involved in the regulation of gene expression [4, 5]. It is possible that this spatial arrangement is altered by chromosome splitting using our method, which may cause a gene expression and epigenetic state change: since telomere ends are invariably anchored to inner nuclear membrane [17], the de novo telomere generated as a result of splitting chromosome may be also tethered to inner nuclear membrane, and this tethering of the de novo telomere may cause large-scale rearrangement of chromosomes. As our method allows the generation of de novo telomere ends at any genomic loci, it is possible to alter spatial arrangement of chromosomes specifically at locus of interest. For example, the spatial arrangement of heterochromatic regions, where infected RBC-surface antigens and the sex-specific transcription factor ap2-gare located, may be altered by our method, which may allow us for investigating mechanisms of host immune evasion and sexual development of parasites. Therefore, our method will assist for further understanding of parasite’s life cycle from the view of spatial arrangement of chromosomes.The normal mitotic division of split-Ch1-1116 parasites in RBCs indicated that de novo centromere functioned properly: it acted as the specific genomic site for assembling kinetochores which is the protein complex to direct chromosome movement along spindle microtubule [18]. The formation of kinetochore requires a centromere-specific histone H3, called CENP-A [19]. Thus, the CENP-A must be loaded specifically on the de novo centromere of the split chromosome and maintained epigenetically. This specific loading of CEMP-A highly depends on the sequence of centromere. Since the linear donor template containing centromere was nucleosome-free DNA fragment, there is no factors other than the sequence. This unique sequence dependency of CENP-A loading of Plasmodium parasite is considered to be one of the factors for successful splitting of the chromosome. Our Southern blotting analyses of split-Ch1-1116 and -1053 showed that de novo telomeres were elongated by telomerase and their length was regulated constantly. These results indicated that de novo telomeres were recognized by not only telomerase, but also other telomere binding proteins [20, 21], similar to the original telomere. This recognition by telomere-associated molecules allowed the introduced telomeric sequences to function normally, protecting the ends of the split chromosomes and contributing to their stability in transgenic parasites. Therefore, we consider that this could be another factor for splitting chromosomes.In conclusion, we demonstrated that the chromosome could be split by CRISPR/Cas9 system using telomere and centromere. In contrast to this method, there is a method for the fusion of chromosome ends using CRISPR/Cas9 system: all chromosomes were fused in Saccharomyces cerevisiae, which generated one or two chromosomes encoding all genes. Theoretically, a similar method could be developed in P. berghei. Combining these splitting/fusing methods, the chromosomes will be rearranged in large-scale which will provide us a strong tool for investigating the role of the spatial arrangement of chromosomes in gene expression.
Oligonucleotides used in this study.
(XLSX)Click here for additional data file.
Maps of donor plasmids constructed for the chromosome split experiment.
(TIFF)Click here for additional data file.
Illustrations of split chromosome 1 and de novo telomere end of split site.
(TIFF)Click here for additional data file.
CRISPR/Cas9-based chromosome split in the split-Ch1-1053 parasites.
(TIFF)Click here for additional data file.
Original gel and blot images.
(PDF)Click here for additional data file.13 Dec 2021
PONE-D-21-34882
Chromosome splitting of Plasmodium berghei using the CRISPR/Cas9 system.
PLOS ONE
Dear Dr. Shiroh Iwanaga ,Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process.
First, I would like to apologize for the time taken to arrive at a decision (Minor Revision) that was due to any potential qualified reviewers declining our invitation to review your submission. One person did accept and luckily she is a real expert in P. berghei chromosome modifications and so, I took the editorial decision based on only this single review. When submitting your revised manuscript please make absolutely clear in your rebuttal letter how you addressed her comments, as this will allow me to make a rapid editorial decision without sending your revision back out for review.
Please submit your revised manuscript by Jan 27 2022 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.Please include the following items when submitting your revised manuscript:
A rebuttal letter that responds to each point raised by the academic editor and reviewer(s). You should upload this letter as a separate file labeled 'Response to Reviewers'.A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled 'Revised Manuscript with Track Changes'.An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled 'Manuscript'.If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter.If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols. Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols.We look forward to receiving your revised manuscript.Kind regards,Gordon LangsleyAcademic EditorPLOS ONEJournal Requirements:When submitting your revision, we need you to address these additional requirements.1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found athttps://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf andhttps://journals.plos.org/plosone/s/file?id=ba62/PLOSOne_formatting_sample_title_authors_affiliations.pdf2. To comply with PLOS ONE submissions requirements, in your Methods section, please provide additional information on the animal research and ensure you have included details on (1) methods of sacrifice, (2) methods of anesthesia and/or analgesia, and (3) efforts to alleviate suffering.3. PLOS ONE now requires that authors provide the original uncropped and unadjusted images underlying all blot or gel results reported in a submission’s figures or Supporting Information files. This policy and the journal’s other requirements for blot/gel reporting and figure preparation are described in detail at https://journals.plos.org/plosone/s/figures#loc-blot-and-gel-reporting-requirements and https://journals.plos.org/plosone/s/figures#loc-preparing-figures-from-image-files. When you submit your revised manuscript, please ensure that your figures adhere fully to these guidelines and provide the original underlying images for all blot or gel data reported in your submission. See the following link for instructions on providing the original image data: https://journals.plos.org/plosone/s/figures#loc-original-images-for-blots-and-gels.In your cover letter, please note whether your blot/gel image data are in Supporting Information or posted at a public data repository, provide the repository URL if relevant, and provide specific details as to which raw blot/gel images, if any, are not available. Email us at plosone@plos.org if you have any questions.4. We note that Figures 3 and 4 in your submission contain copyrighted images. All PLOS content is published under the Creative Commons Attribution License (CC BY 4.0), which means that the manuscript, images, and Supporting Information files will be freely available online, and any third party is permitted to access, download, copy, distribute, and use these materials in any way, even commercially, with proper attribution. For more information, see our copyright guidelines: http://journals.plos.org/plosone/s/licenses-and-copyright.We require you to either (1) present written permission from the copyright holder to publish these figures specifically under the CC BY 4.0 license, or (2) remove the figures from your submission:a. You may seek permission from the original copyright holder of Figures 3 and 4 to publish the content specifically under the CC BY 4.0 license.We recommend that you contact the original copyright holder with the Content Permission Form (http://journals.plos.org/plosone/s/file?id=7c09/content-permission-form.pdf) and the following text:“I request permission for the open-access journal PLOS ONE to publish XXX under the Creative Commons Attribution License (CCAL) CC BY 4.0 (http://creativecommons.org/licenses/by/4.0/). Please be aware that this license allows unrestricted use and distribution, even commercially, by third parties. Please reply and provide explicit written permission to publish XXX under a CC BY license and complete the attached form.”Please upload the completed Content Permission Form or other proof of granted permissions as an ""Other"" file with your submission.In the figure caption of the copyrighted figure, please include the following text: “Reprinted from [ref] under a CC BY license, with permission from [name of publisher], original copyright [original copyright year].”b. If you are unable to obtain permission from the original copyright holder to publish these figures under the CC BY 4.0 license or if the copyright holder’s requirements are incompatible with the CC BY 4.0 license, please either i) remove the figure or ii) supply a replacement figure that complies with the CC BY 4.0 license. Please check copyright information on all replacement figures and update the figure caption with source information. If applicable, please specify in the figure caption text when a figure is similar but not identical to the original image and is therefore for illustrative purposes only.5. Thank you for stating the following financial disclosure:All studies were supported by Grants-in-Aid for Scientific Research (20H03477 and 19K22527 to S.I. 18K07084 and 21K06985 to N.S., and 17H01542 to M.Y.), which were funded by the Japan Society for the Promotion of Science (JSPS: https://www.jsps.go.jp/), and also supported by the Japan Agency for Medical Research and Development (AMED: https://www.amed.go.jp/) under Grant Number 21jm0210061h0004 (to S.I.), 21wm0325018 (to N.S.) and 21wm0225014 (to N.S.).Please state what role the funders took in the study. If the funders had no role, please state: ""The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.""If this statement is not correct you must amend it as needed.Please include this amended Role of Funder statement in your cover letter; we will change the online submission form on your behalf.6. Please review your reference list to ensure that it is complete and correct. If you have cited papers that have been retracted, please include the rationale for doing so in the manuscript text, or remove these references and replace them with relevant current references. Any changes to the reference list should be mentioned in the rebuttal letter that accompanies your revised manuscript. If you need to cite a retracted article, indicate the article’s retracted status in the References list and also include a citation and full reference for the retraction notice.[Note: HTML markup is below. Please do not edit.]Reviewers' comments:Reviewer's Responses to Questions
Comments to the Author1. Is the manuscript technically sound, and do the data support the conclusions?The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented. Reviewer #1: Yes********** 2. Has the statistical analysis been performed appropriately and rigorously? Reviewer #1: Yes********** 3. Have the authors made all data underlying the findings in their manuscript fully available?The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified. Reviewer #1: Yes********** 4. Is the manuscript presented in an intelligible fashion and written in standard English?PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here. Reviewer #1: Yes********** 5. Review Comments to the AuthorPlease use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters) Reviewer #1: SummaryThe authors here present a study where they have generated a CRISPR/Cas9-based tool which facilitates the site-specific cleavage of Plasmoidum berghei chromosomes. By introduction of additional telomere and centromere elements together with the homology directed repair template, they can thereby generate transgenic parasite lines with split chromosomes that segregate and are faithfully maintained during cell division. The study builds upon improvements to the P. berghei CRISPR/Cas9 system that the some of the authors published earlier. They here report on the on the modifications to the system that enables chromosome splitting, the vector generation and proof of principle experiments where they split P. berghei chromosome 1 in two different (blood-stage) functionally redundant loci. They further report on the normal viability and lack of fitness effect for (one of the?) split chromosome 1 lines.Impact and qualityThis is a well written manuscript with clearly presented methods and results, and where conclusions are well supported by data. Data is of good quality and is underpinned by appropriate controls. The merit of this study is that it presents a for malaria parasites completely novel system to split chromosomes and generate viable progeny with split chromosomes. This tool in turn, as argued by the authors, makes it possible to study the effect of intra-nuclear spatial location of chromosomes, which the authors argue “may cause a gene expression and epigenetic state change: since telomere ends are invariably anchored to inner nuclear membrane”. They further suggest this will be a particularly useful tool to study the effect of intra-nuclear spatial localization on expression of multigene surface proteins and genes important for sexual development since they localize to the subtelomeric regions of malaria parasite chromosomes.The impact of the study is limited by that the authors present no evidence for change in intra-nuclear spatial location of split chromosomes (e.g. FISH) or of gene expression (e.g. RNA seq) due to chromosome splitting. Could one not instead argue that no change in gene expression is likely to occur due to chromosome splitting, since no observable change in phenotype is shown for the chromosome 1 split line? The impact of this system on our understanding of malaria parasite biology there for remain hypothetical. This type of data would significantly elevate the impact of the study. Nevertheless, that elevation would likely qualify it for a higher impact journal and I have no reservations in recommending the manuscript for publication as it is, with only minor revisions outlined below.Minor revisions41 considered recently -> recently considered95 this plasmid can be screened -> this plasmid can be selected?103 perhaps will aid reader if you explain centric / acentric chromosome?277 “… we compared the asexual multiplication of split-Ch1-S parasite to that of pbcas9”. Clarify here if split-Ch1-S is PBANKA_0111600 or PBANKA_0105300 line. Perhaps it is stipulated in methods or elsewhere but would be good to make more obvious. This goes for all figures too, it is not always immediately clear to the reader which split chromosome line you refer to.Fig S4 Mislabeling, two Panel D instead of E********** 6. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.If you choose “no”, your identity will remain anonymous but your review may still be made public.Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy. Reviewer #1: Yes: Ellen Bushell[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.]While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step.
18 Jan 2022Reviewer’s CommentsReviewer #1: SummaryThe authors here present a study where they have generated a CRISPR/Cas9-based tool which facilitates the site-specific cleavage of Plasmoidum berghei chromosomes. By introduction of additional telomere and centromere elements together with the homology directed repair template, they can thereby generate transgenic parasite lines with split chromosomes that segregate and are faithfully maintained during cell division. The study builds upon improvements to the P. berghei CRISPR/Cas9 system that the some of the authors published earlier. They here report on the on the modifications to the system that enables chromosome splitting, the vector generation and proof of principle experiments where they split P. berghei chromosome 1 in two different (blood-stage) functionally redundant loci. They further report on the normal viability and lack of fitness effect for (one of the?) split chromosome 1 lines.Impact and quality This is a well written manuscript with clearly presented methods and results, and where conclusions are well supported by data. Data is of good quality and is underpinned by appropriate controls. The merit of this study is that it presents a for malaria parasites completely novel system to split chromosomes and generate viable progeny with split chromosomes. This tool in turn, as argued by the authors, makes it possible to study the effect of intra-nuclear spatial location of chromosomes, which the authors argue “may cause a gene expression and epigenetic state change: since telomere ends are invariably anchored to inner nuclear membrane”. They further suggest this will be a particularly useful tool to study the effect of intra-nuclear spatial localization on expression of multigene surface proteins and genes important for sexual development since they localize to the subtelomeric regions of malaria parasite chromosomes. The impact of the study is limited by that the authors present no evidence for change in intra-nuclear spatial location of split chromosomes (e.g. FISH) or of gene expression (e.g. RNA seq) due to chromosome splitting. Could one not instead argue that no change in gene expression is likely to occur due to chromosome splitting, since no observable change in phenotype is shown for the chromosome 1 split line? The impact of this system on our understanding of malaria parasite biology there for remain hypothetical. This type of data would significantly elevate the impact of the study. Nevertheless, that elevation would likely qualify it for a higher impact journal and I have no reservations in recommending the manuscript for publication as it is, with only minor revisions outlined below.Response:Thank you for reviewing our manuscript to make it better. The details of the modifications according to your comments are described below.Minor revisions1. 41 considered recently -> recently consideredResponseThank you for pointing-out this grammatical error. We have modified the phase from “considered recently” to “recently considered” on line 41.2. 95 this plasmid can be screened -> this plasmid can be selected?ResponseWe have changed the word “screened” to “selected” on line 98.3. 103 perhaps will aid reader if you explain centric / acentric chromosome?ResponseThank you for this suggestion. We have included an explanation in parenthesis for both acentric and centric chromosomes. This can be seen from lines 108 to 112 as follows:This linear DNA fragment was used for HDR with the centric chromosome (Chromosome 1 fragment with the original centromere after cleavage) after cleavage by the Cas9-sgRNA complex. Another DNA fragment, which was used for HDR with the acentric chromosome (Chromosome 1 fragment lacking a centromere after cleavage), was amplified and cloned upstream of both telomere and centromere of pArm_R plasmid (S2 Fig)” (P.5,l.106-P.6,l.110)4. 277 “… we compared the asexual multiplication of split-Ch1-S parasite to that of pbcas9”. Clarify here if split-Ch1-S is PBANKA_0111600 or PBANKA_0105300 line. Perhaps it is stipulated in methods or elsewhere but would be good to make more obvious. This goes for all figures too, it is not always immediately clear to the reader which split chromosome line you refer to.ResponseThank you for this observation. In order to make it easier to understand which mutant parasite is being referred-to, the labeling for the mutants have been modified. For example, split-Ch1-S has been changed to split-Ch1-1116. “1116” indicates that the mutant was produced by splitting the parent parasite at the PBANKA_0111600 locus. Similarly, split-Ch1-L has been changed to split-Ch1-1053. Also, “1053” indicates that the mutant was produced by splitting the parent parasite at the PBANKA_0105300 locus. This change has been effected throughout the text and figures.5. Fig S4 Mislabeling, two Panel D instead of EResponseThank you for pointing-out this mistake. The mislabeled “D” panel has been re-labeled as “E” in the S4 Fig caption.Submitted filename: Response to Reviewers_211224__SI.docxClick here for additional data file.9 Feb 2022Chromosome splitting of Plasmodium berghei using the CRISPR/Cas9 system.PONE-D-21-34882R1Dear Dr. Shiroh Iwanaga ,We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements.Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication.An invoice for payment will follow shortly after the formal acceptance. To ensure an efficient process, please log into Editorial Manager at http://www.editorialmanager.com/pone/, click the 'Update My Information' link at the top of the page, and double check that your user information is up-to-date. If you have any billing related questions, please contact our Author Billing department directly at authorbilling@plos.org.If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org.Kind regards,Gordon LangsleyAcademic EditorPLOS ONEAdditional Editor Comments (optional):Reviewers' comments:14 Feb 2022PONE-D-21-34882R1Chromosome splitting of Plasmodium berghei using the CRISPR/Cas9 system.Dear Dr. Iwanaga:I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now with our production department.If your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information please contact onepress@plos.org.If we can help with anything else, please email us at plosone@plos.org.Thank you for submitting your work to PLOS ONE and supporting open access.Kind regards,PLOS ONE Editorial Office Staffon behalf ofDr. Gordon LangsleyAcademic EditorPLOS ONE
Authors: Nicole L Bertschi; Christa G Toenhake; Angela Zou; Igor Niederwieser; Rob Henderson; Suzette Moes; Paul Jenoe; John Parkinson; Richard Bartfai; Till S Voss Journal: Nat Microbiol Date: 2017-03-13 Impact factor: 17.745
Authors: Pratima Gurung; Ana Rita Gomes; Rafael M Martins; Stefan A Juranek; Patrizia Alberti; Diane-Ethna Mbang-Benet; Serge Urbach; Elodie Gazanion; Vincent Guitard; Katrin Paeschke; Jose-Juan Lopez-Rubio Journal: Cell Microbiol Date: 2021-01-18 Impact factor: 3.715
Authors: Ferhat Ay; Evelien M Bunnik; Nelle Varoquaux; Sebastiaan M Bol; Jacques Prudhomme; Jean-Philippe Vert; William Stafford Noble; Karine G Le Roch Journal: Genome Res Date: 2014-03-26 Impact factor: 9.043
Authors: Evelien M Bunnik; Kate B Cook; Nelle Varoquaux; Gayani Batugedara; Jacques Prudhomme; Anthony Cort; Lirong Shi; Chiara Andolina; Leila S Ross; Declan Brady; David A Fidock; Francois Nosten; Rita Tewari; Photini Sinnis; Ferhat Ay; Jean-Philippe Vert; William Stafford Noble; Karine G Le Roch Journal: Nat Commun Date: 2018-05-15 Impact factor: 14.919